» Articles » PMID: 2502462

Persistent Reduction of CD4/CD8 Lymphocyte Ratio and Cell Activation Before the Onset of Type 1 (insulin-dependent) Diabetes

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1989 May 1
PMID 2502462
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.

Citing Articles

Systemic immune response in young and elderly patients after traumatic brain injury.

Magatti M, Pischiutta F, Ortolano F, Pasotti A, Caruso E, Cargnoni A Immun Ageing. 2023; 20(1):41.

PMID: 37573338 PMC: 10422735. DOI: 10.1186/s12979-023-00369-1.


A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes.

Girdhar K, Huang Q, Chow I, Vatanen T, Brady C, Raisingani A Proc Natl Acad Sci U S A. 2022; 119(31):e2120028119.

PMID: 35878027 PMC: 9351354. DOI: 10.1073/pnas.2120028119.


eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes.

Imam S, Prathibha R, Dar P, Almotah K, Al-Khudhair A, Hasan S Sci Rep. 2019; 9(1):1533.

PMID: 30733517 PMC: 6367423. DOI: 10.1038/s41598-018-38341-5.


Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?.

McBride J, Striker R PLoS Pathog. 2017; 13(11):e1006624.

PMID: 29095912 PMC: 5667733. DOI: 10.1371/journal.ppat.1006624.


HLA-A*33-DR3 and A*33-DR9 haplotypes enhance the risk of type 1 diabetes in Han Chinese.

Zhang J, Zhao L, Wang B, Gao J, Wang L, Li L J Diabetes Investig. 2016; 7(4):514-21.

PMID: 27181214 PMC: 4931201. DOI: 10.1111/jdi.12462.


References
1.
Hayward A, Herberger M . Culture and phenotype of activated T-cells from patients with type I diabetes mellitus. Diabetes. 1984; 33(4):319-23. DOI: 10.2337/diab.33.4.319. View

2.
Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C . Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia. 1987; 30(10):817-9. DOI: 10.1007/BF00275749. View

3.
Reinherz E, Schlossman S . The differentiation and function of human T lymphocytes. Cell. 1980; 19(4):821-7. DOI: 10.1016/0092-8674(80)90072-0. View

4.
Pozzilli P, Sensi M, Tarn A, Zuccarini O, Bottazzo G . Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetes. Diabetologia. 1984; 27 Suppl:132-5. DOI: 10.1007/BF00275670. View

5.
Smith S, Brown M, Rowe D, Callard R, Beverley P . Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology. 1986; 58(1):63-70. PMC: 1452633. View